CMO Letter 

Dear Prospective Partner,

​

In the dynamic healthcare landscape, where innovation and efficiency are paramount, we are energized to grow AxioMed and NANISX, two pioneering global medical device company leading the way in viscoelastic disc replacement and outpatient spine surgery. We envision a future where outpatient spine surgery is the standard, driven by disc replacements and cutting-edge LESS™ Exposure Spine Surgery techniques and revolutionary technologies, avoiding the risk of traditional spine fusions.

​

LESS™ Exposure Spine Surgery is our unique philosophy that guides our approach. With LESS™, we aim to minimize tissue disruption, reduce postoperative pain, and accelerate recovery, all contributing to an unparalleled patient experience.

​

NANISX leverages over 20 years of committed experience, constantly changing and staying at the forefront of technological advancements. Our spinal devices are meticulously designed driven by expert surgeons, ensuring precision and effectiveness in every procedure. Our commitment to excellence and innovation sets us apart, and we take a long-term view on achieving sustainable growth.

​

We are proud to offer you a unique investment opportunity for physicians and patients to partner with us with a shared vision of leaving a lasting legacy of innovative technologies for future generations.

​

Together we will create a legacy of innovative technologies that will impact generations.

 

 

Sincerely,

 

Erik C. Spayde MD

Harvard-Trained | Board-certified Orthopedic Spine Surgeon

Chief Medical Officer

KIC Ventures

​